Indaptus Therapeutics Net Income vs. Debt To Equity
| INDP Stock | USD 1.00 0.01 0.99% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -15.4 M | Current Value -16.2 M | Quarterly Volatility 17.9 M |
For Indaptus Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Indaptus Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Indaptus Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Indaptus Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Indaptus Therapeutics over time as well as its relative position and ranking within its peers.
Indaptus |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Indaptus Therapeutics. If investors know Indaptus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Indaptus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.70) | Return On Assets (0.71) | Return On Equity (1.27) |
The market value of Indaptus Therapeutics is measured differently than its book value, which is the value of Indaptus that is recorded on the company's balance sheet. Investors also form their own opinion of Indaptus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Indaptus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Indaptus Therapeutics' market value can be influenced by many factors that don't directly affect Indaptus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Indaptus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Indaptus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Indaptus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Indaptus Therapeutics Debt To Equity vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Indaptus Therapeutics's current stock value. Our valuation model uses many indicators to compare Indaptus Therapeutics value to that of its competitors to determine the firm's financial worth. Indaptus Therapeutics is rated second overall in net income category among its peers. It is rated below average in debt to equity category among its peers . Indaptus Therapeutics reported last year Net Loss of (15.42 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Indaptus Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Indaptus Debt To Equity vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Indaptus Therapeutics |
| = | (15.42 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Indaptus Therapeutics |
| = | 0 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Indaptus Debt To Equity Comparison
Indaptus Therapeutics is currently under evaluation in debt to equity category among its peers.
Indaptus Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Indaptus Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Indaptus Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Indaptus Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Indaptus Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -16.4 M | -17.2 M | |
| Income Before Tax | -15.4 M | -16.2 M | |
| Total Other Income Expense Net | 955 K | 1 M | |
| Net Loss | -12.9 M | -12.2 M | |
| Net Loss | -15.4 M | -16.2 M | |
| Income Tax Expense | -16.4 M | -15.6 M | |
| Net Interest Income | 676.3 K | 710.1 K | |
| Interest Income | 676.3 K | 710.1 K | |
| Net Loss | -15.1 M | -15.8 M | |
| Change To Netincome | 3.2 M | 3.4 M | |
| Net Loss | (1.84) | (1.93) | |
| Income Quality | 0.87 | 0.75 | |
| Net Income Per E B T | 1.10 | 1.09 |
Indaptus Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Indaptus Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Indaptus Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Indaptus Therapeutics' important profitability drivers and their relationship over time.
Use Indaptus Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.Indaptus Therapeutics Pair Trading
Indaptus Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Indaptus Therapeutics position
In addition to having Indaptus Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Software Thematic Idea Now
Software
Companies that develop and distribute software and software systems to individuals or business. The Software theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Software Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.